SCHEMBL2156309

SCHEMBL2156309

COC(=O)c1cc2c(s1)c(-c1ccccc1)c(Br)n2C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 3/20 0.38
NR1H2 P55055 11/20 0.37
NR1H3 Q13133 1/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PKM P14618 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
GRM6 O15303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230446 0.93 NR1H2 (0.38) ALDH1A1LMNANR1H2NR1H3KDM4E
SCHEMBL2986524 0.82 ALDH1A1 (0.40) ALDH1A1LMNAMAPTNR1H2NR1H3
SCHEMBL2156914 0.82 ALDH1A1 (0.39) ALDH1A1LMNAMAPTHPGDKDM4E
SCHEMBL2157504 0.78 KDM4E (0.39) ALDH1A1LMNAMAPTHPGDKDM4E
SCHEMBL2998154 0.77 MEN1 (0.40) ALDH1A1LMNAMAPTHPGDKDM4E
SCHEMBL2156666 0.77 KMT2A (0.39) ALDH1A1LMNAMAPTHPGDKDM4E
SCHEMBL2157158 0.76 KDM4E (0.42) ALDH1A1LMNAMAPTHPGDKDM4E
SCHEMBL2156302 0.75 USP30 (0.35) ALDH1A1MAPTNR1H2HPGDKDM4E
SCHEMBL2998711 0.74 ALDH1A1 (0.42) ALDH1A1LMNAMAPTHPGDKDM4E
SCHEMBL2157091 0.70 KDM4E (0.43) ALDH1A1LMNAMAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973026-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-05 US disclosed
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US disclosed
US-20090105227-A1 Thienopyrroles As Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-04-23 US disclosed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US disclosed
EP-1664059-B1 THIENOPYRROLES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2007-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105227-A1 Thienopyrroles As Antiviral Agents ZC3HAV1, HAVCR2, ZC3HAV1L ALDH1A1 433/4885LMNA 4377/4885MAPT 3980/4885
US-20090036443-A1 Thienopyrroles as antiviral agents ZC3HAV1, XDH, TPMT ALDH1A1 397/4885LMNA 3405/4885MAPT 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.